Suboptimal medication use and mortality in an older adult community-based cohort: Results from the Hispanic EPESE study

被引:76
作者
Espino, DV
Bazaldua, OV
Palmer, RF
Mouton, CP
Parchman, ML
Miles, TP
Markides, K
机构
[1] Univ Texas, Hlth Sci Ctr, Dept Family & Community Med, San Antonio, TX 78229 USA
[2] Howard Univ, Coll Med, Dept Community & Family Med, Washington, DC 20059 USA
[3] Univ Louisville, Dept Family & Geriatr Med, Louisville, KY 40292 USA
[4] Univ Texas, Med Branch, Dept Community Hlth & Prevent Med, Div Sociomed Sci, Galveston, TX 77550 USA
来源
JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES | 2006年 / 61卷 / 02期
关键词
D O I
10.1093/gerona/61.2.170
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Background. Numerous methods have been used to evaluate medication management quality in older adults; however, their predictive validities are unknown. Major medication quality indicators include polypharmacy, drug-drug interactions, and inappropriate medication use. To date, no study has attempted to evaluate the three approaches systematically or the effect of each approach on mortality in a Hispanic population. Our objective was to evaluate the relationship between polypharmacy, drug-drug interactions, and inappropriate medication use on the mortality of a community-based population of Mexican American older adults. Methods. We used a life table survival analysis of a longitudinal survey of a representative sample of 3050 older Mexican Americans of whom 1823 were taking prescription and over-the-counter medications. Results. After adjustment for relevant covariates, use of more than four different medications (polypharmacy) was independently associated with mortality. The presence of major drug interactions and the use of inappropriate medications were not significantly associated with mortality in our study sample. Conclusion. Polypharmacy (> 4 medications) is significantly associated with mortality in Mexican American older adults. This community-based study is the first to demonstrate a direct association between polypharmacy and mortality in this population.
引用
收藏
页码:170 / 175
页数:6
相关论文
共 31 条
[1]  
[Anonymous], SAS STAT US GUID VER
[2]  
[Anonymous], 2003, PRIORITY AREAS NATL
[3]  
BEERS MH, 1991, ARCH INTERN MED, V151, P1825
[4]   Polypharmacy: Correlations with sex, age and drug regimen - A prescription database study [J].
Bjerrum, L ;
Sogaard, J ;
Hallas, J ;
Kragstrup, J .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (03) :197-202
[5]  
BLACK SA, 2003, RESOURCE BOOK HISPAN, P1
[6]   Healthy ageing: ageing safely [J].
Buckley, BM .
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2001, 3 (0N) :N6-N10
[7]  
Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P664
[8]  
Cox D. R., 1984, Analysis of survival data
[9]   HAZARDS OF HOSPITALIZATION OF THE ELDERLY [J].
CREDITOR, MC .
ANNALS OF INTERNAL MEDICINE, 1993, 118 (03) :219-223
[10]  
Ernst F R, 2001, J Am Pharm Assoc (Wash), V41, P192